These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15717161)

  • 1. Role of urinary supersaturation in the evaluation of children with urolithiasis.
    Lande MB; Varade W; Erkan E; Niederbracht Y; Schwartz GJ
    Pediatr Nephrol; 2005 Apr; 20(4):491-4. PubMed ID: 15717161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate?
    Battino BS; DeFOOR W; Coe F; Tackett L; Erhard M; Wacksman J; Sheldon CA; Minevich E
    J Urol; 2002 Dec; 168(6):2568-71. PubMed ID: 12441985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a prospective trial to compare normal urine supersaturation in children and adults.
    Defoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Minevich E
    J Urol; 2005 Oct; 174(4 Pt 2):1708-10. PubMed ID: 16148687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.
    Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Anderson JK; Monga M
    J Endourol; 2011 Mar; 25(3):535-40. PubMed ID: 21361824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS; Wilson DM; Smith LH
    Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary supersaturation with calcium oxalate before and during orthophosphate therapy.
    Burdette DC; Thomas WC; Finlayson B
    J Urol; 1976 Apr; 115(4):418-22. PubMed ID: 1263318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposing factors for infantile urinary calculus in south-west of Iran.
    Alemzadeh-Ansari MH; Valavi E; Ahmadzadeh A
    Iran J Kidney Dis; 2014 Jan; 8(1):53-7. PubMed ID: 24413722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportional reduction of urine supersaturation during nephrolithiasis treatment.
    Coe FL; Wise H; Parks JH; Asplin JR
    J Urol; 2001 Oct; 166(4):1247-51. PubMed ID: 11547051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
    J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.